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Objectives: to prospectively evaluate the mid-term results of endovascular and open repair in patients with abdominal
aortic aneurysm (AAA) anatomically suitable for endovascular repair.
Material and methods: between January 1995 and March 1999, among 438 patients treated for AAA, 180 (41%) were
suitable for endovascular repair as assessed by computed tomography (CT) scan and angiogram. Seventy-three were
treated by various commercially available endovascular grafts (EV) and 107 by open repair (OR). Postoperatively, patients
were followed every 6 months with clinical examination, duplex scan and in the EV group, CT scans. Patients’ demographic
data, intra- and postoperative events were recorded prospectively in a computerised database and compared for each group.
Results: median age, sex ratio, preoperative risk factors and aneurysm diameters were not statistically different between
the two groups.
Respectively in the EV and OR, the average duration of operation was 149±73 mn, and 133±44 mn (NS), blood loss
96 ml±28 and 985 ml±113 (p<0.01), duration of hospitalisation 7 days±2 and 13 days±7 (p<0.01).
The one-month mortality was 2.7% (n=2) for EV and 2.8% (n=3) for OR. The rate of cardiac and pulmonary
complications was significantly higher in the OR group (6.9% versus 19.6%, p=0.017).
At a mean follow-up of 1 year, the cumulative survival rate was 82.2%±7.5 for EV and 96%±2.12 for OR (log-rank
test p=0.043). No patients died of rupture, but three patients had to be converted to open surgery. Twenty-two percent
(n=16) patients in the EV and 7.5% (n=8) in the OR were submitted to a subsequent minor or major reintervention
(p=0.007). At 1 year, the cumulative rates free of any reintervention were respectively 78.8%±6.7% and 92.9%±2.7%
(p=0.001). In the EV there were 17 early endoleaks (23.3%). At the end of patient’s follow-up seven endoleaks (9.6%)
persisted. The primary success rate defined by the absence of endoleak and the absence of reintervention was 54 (74%)
with EV and 101 (94%) with OR (p=0.001).
Conclusion: EV is a promising technique. However, with current devices and indications the immediate benefits, mainly
less blood loss, fewer cardiac and pulmonary complications, and shorter hospitalisation time, are outweighed by a higher
rate of reinterventions to treat endoleak, or to maintain patency of the graft.
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Introduction endovascular repair are generally good, with a mor-
tality rate varying from 0% to 4.5%.4–8 However, since
Endovascular repair of abdominal aortic aneurysm the technology is recent and rapidly evolving, only a
(AAA) is currently proposed as an alternative to open few reports are available to assess the mid-term results
surgery1 because it is less invasive for patients who of endovascular repair as compared to those of open
have severe co-morbidity and a risk of early death surgery. The main uncertainty remains the long-term
from open surgery close to 5.5%.2,3 Early results of efficacy of the EV repair,9 which may be threatened
by endoleaks, graft distortion, limb graft occlusion,
and material fatigue. Thus, with the current lack of∗ This work was presented at the ESVS annual meeting in Copen-
scientific evidence, the most appropriate procedurehagen, Denmark 3–5 September 1999
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France. results of endovascular versus open repair in patients
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with AAA anatomically suitable for endovascular studied in the EV group. Endoleaks were defined
according to the modified classification of White.10,11repair.
Type I and type III endoleaks were treated ag-
gressively; type II endoleaks were managed more
conservatively. In the latter case, intervention was only
Materials and Methods done when the aneurysm diameter increased by 20%
on surveillance CT scans.
Between January 1995 and March 1999, 438 patients The main endpoints were death and reintervention.
referred to our institution for elective AAA repair The latter included, for both groups, various open or
were routinely assessed by CT scan and angiogram. endovascular procedures performed to treat com-
One hundred and eighty (41%) were considered to be plications, to improve or to restore patency of the graft
anatomically suitable for endovascular repair since or limb and/or graft replacement; and, in the EV
they fulfilled the following criteria: upper neck group, attempt to close endoleaks.
[1.5 cm in length and less than 30 mm in diameter, The statistical analysis included the Chi-squared
preservation of at least one patent non-aneurysmal test, Student’s t-test, life-table analysis and log-rank
internal iliac artery, no major angulation of the aorta test.
and/or the iliac arteries, and iliac arteries without
extensive occlusive disease or calcification. The choice
between open and endovascular repair varied over
the period of the study. The first endovascular cases Results
were high-risk patients. However, with increasing ex-
pertise and confidence, in the last 2 years of the They were 107 OR and 73 EV. Median age, sex ratio,
and preoperative risk factors are listed in Table 1.series, when the anatomical criteria were met, the
endovascular technique was proposed as a first option The distribution of risk factors was not statistically
different. However, when we investigated the as-as soon as the hospital resources allowed the purchase
of the devices, and the patients accepted the un- sociation of the following risk factors (diabetes mel-
litus, severe obesity, unstable angina, left-ventricularcertainty of the EV repair and signed an informed
consent. Only commercially available grafts were im- ejection fraction <30%, renal insufficiency defined by
a creatinine level >200 mol/l or dialysis, and severeplanted. Bifurcated grafts were chosen whenever pos-
sible. Aorto-uni-iliac grafts, with occlusion of the respiratory insufficiency defined by VEMS <1.2 l and/
or pCO2 >45 mmHg), the percentage of patients withcontralateral common iliac artery by a manufactured
occluder and femorofemoral bypass, were used when two or more risk factors was 8.3% in the OR and 22%
in the EV group (p=0.01). Average aneurysm diameterone of the iliac arteries was unsuitable (too large,
angulated or diseased). was 50.5 mm±11 mm in the OR and 50 mm±5.5 mm
in the EV group (NS).Postoperatively, patients were followed on an out-
patient basis. Patients with open repair had a visit at In the EV group, various endovascular grafts were
implanted. They consisted of 46 Vanguard (Boston1 month postoperatively and then yearly thereafter,
with clinical examinations and duplex scans of the Scientific, St. Quentin les Yvelines, France), 9 Endo-
VascularTechnology (Guidant, Rueil-Malmaison,graft and adjacent vessels. Patients with endovascular
grafts were submitted to CT scan examination, with 92504, France), eight Stentor (Mintec, Bahamas), eight
Stenway (Stenford, Paris, France) and two Talent graftsand without contrast medium, within the first month
post-op, at 3 months, 6 months, 1 year, 18 months, 2 (World Medical, Medtronic, Rueil-Malmaison 92566,
France). The type of graft used was as follows: 67years, and yearly thereafter.
Preoperative risk factors were graded according to bifurcated grafts, three tube grafts, and three aorto-
uni-iliac and femorofemoral grafts. Intraoperative datathe SVS/ISCVS classification. They were recorded pro-
spectively in a computerised database (J. Meunier, are shown in Table 2. Postoperatively, the duration of
hospitalisation was 13 days±7 for OR and 7 days±2Logit), as well as imaging parameters, intraoperative
data, and postoperative events. for EV (p<0.01).
The 1-month mortality was 2 (2.7%) for EV and 2Between January 1999 and August 1999, the database
was checked and missing data entered whenever pos- (2.8%) for OR. In the OR group, the causes of death
were two myocardial infarcts and one complicatedsible. Patients who had not complied with the sur-
veillance protocol were contacted by phone and pneumonia. In the EV group, the two deaths may have
been graft-related. One of these patients, who hadsubmitted to the expected visit and examination.
Endoleaks and aneurysm diameters were also been denied open repair due to severe co-morbidities,
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Table 1. Distribution of preoperative risk factors in endovascular (EV) and open repair (OR).
Endovascular repair Open repair
n % n % p
Mean age (years) 70 69
Sex (M/F) 66/7 100/7
Ischaemic heart disease 41 (56.2%) 46 (43%) NS
Previous MI 14 (19.2%) 19 (17.7%) NS
Arrhythmia 6 (8.2%) 10 (9.3%) NS
Obesity 19 (26%) 29 (27%) NS
Smoking 25 (34.2%) 39 (36.4%) NS
Hypertension 39 (53.4%) 55 (51.4%) NS
Pulmonary disease 18 (24.6%) 24 (22.4%) NS
Diabetes mellitus 8 (10.9%) 11 (10.3%) NS
Renal impairment 8 (10.9%) 14 (13.1%) NS
Hyperlipaemia 22 (30.3%) 22 (20.6%) NS
Table 2. Intraoperative data of endovascular and open repair of AAA.
Endovascular repair Open repair
n n p
Tube/bifurcation 6/67 37/70 <0.001
Duration of operation 149 133 NS
(median in mn) (range) (40–480 min) (50–250 min)
Blood loss 96 985 <0.05
(median in ml) (range) (0–1200) (200–10 000)
Table 3. Comparison of early local non-vascular and systemic complications of
endovascular and open repair.
Endovascular repair Open repair
n % n %
Local non-vascular
Haematoma 1 (1.4) 2 (1.9)
Lymphocoele 0 0
Wound sepsis 0 0
Systemic or remote
Cardiac 2 (2.7) 7 (6.5)
Pulmonary 3 (4.1) 14 (13.1) (p=0.045)
Renal 3 (4.1) 3 (2.8)
Sepsis 3 (4.1) 2 (1.9)
Neurological 0 2 (1.9)
was treated uneventfully with a Stentor graft. Two Major complications were observed in 28 (26.2%) of
the OR group and 11 (15%) of the EV group (NS)hours later, while in the recovery room, he presented
with septic-like shock and the graft occluded. Despite (Table 3). The rate of cardiac and pulmonary com-
plications was significantly higher in the OR groupemergent thrombectomy and resuscitation measures,
he subsequently died of cardiac insufficiency. The (p=0.017). The local, non-vascular complications rate
was 2 (1.9%) and 1 (1.4%), respectively.second patient, a 79-year-old high-risk patient, was
treated with an EVT device. While deploying the The median follow-up was 7 months in the EV
group (range 4 days to 40 months), and 19 months insecond limb of the graft, the left common iliac artery
was lacerated by the distal metallic hooks. In an at- the OR group (range 4 days to 51 months). During
follow-up, in the EV group, there were three deathstempt to control the bleeding by a retroperitoneal
approach, the vena cava was injured and finally re- from cardiac disease and two from liver and pul-
monary malignancies. In the OR group there were twopaired. The left iliac artery was ligated and a femo-
rofemoral bypass performed. The patient died 5 weeks deaths from cardiac diseases and one from pulmonary
cancer. Cumulative survival is shown in Figure 1.later of multiple organ failure.
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group were converted to open surgery, or because
their aneurysm grew to 65 mm, with no sign of endo-
leak; one because the graft occluded three times, and
one because of a distal endoleak which could not be
treated by a new endovascular graft. All these three
patients remain well.
In total, 16 patients (22%) in the EV and eight (7.5%)
in the OR required a subsequent vascular re-
intervention (p=0.001) (Table 4). Primary success, de-
fined by the absence of endoleak and/or the absence
of reintervention, was 54 (74%) with EV and 101 (94%)
with OR (p=0.001).
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Fig. 1. Life-table analysis of survival in patients treated by endo-
vascular (EV) and open repair (OR).
Discussion
Only a few studies have compared OR and EV for the
treatment of AAA. Early results have been reported
by the Sydney group12 which has compared two groups
of 27 and 28 patients fit and suitable for both OR and
EV. A similar study by Brewster13 included 30 patients
whose data and outcomes were compared to a matched
control group of OR. Early and 6-month results were
also reported by Zarins14 with a multicentre pro-
spective study of 190 AneuRX grafts, which was com-
pared to 60 patients who underwent OR and who met
the criteria for entering the EV group. Finally, the
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Sydney group15 reported a survey of 303 patients withFig. 2. Life-table analysis of survival free of any type of vascular,
data analysed by life-table method. This latter seriesendovascular or miscellaneous reinterventions, in patients treated
by endovascular (EV) and open repair (OR). was historical and the two groups were not strictly
identical. Forty-four percent of patients in the EV
group were poor candidates for open surgery, andOn the first post-operative CT scan there were 17
endoleaks (23.3%) in the EV group: eight type I and patients in the OR group had AAA morphological
features unsuitable for EV.nine type II. On the last available CT scan, there were
five type I and two type II endoleaks. The present prospective study compared 180 con-
secutive patients and was carried out in a single in-In the EV group, 12 grafts occluded or developed a
stenosis (16.4%). Two patients had external iliac artery stitution. Patients in both groups were anatomically
suitable for endovascular repair. Patients with complexstenoses prior to implantation; these were treated by
angioplasty at the time of graft insertion. Two more aneurysms, involving the renal artery and/or ex-
tending down both internal iliac arteries were ex-patients developed external iliac artery stenosis fol-
lowing implantation. Finally, eight patients developed cluded. Of note is that this later group is at higher
risk for early mortality with OR.16 The current studystenosis or thrombosis within the graft itself. In three
EVT grafts, it was thought that the limbs of the graft has, nevertheless, some obvious flaws. The distribution
of procedures varied with time. A great number ofhad twisted. In five modular grafts, the stenosis and
occlusions occurred on the contralateral limb. None patients in the EV group were treated during the most
recent part of this study and have a shorter follow-of these cases were thought due to graft kinking
secondary to AAA remodelling. Thrombolysis and up. The EV group included our very first cases and
suffers the consequence of the learning curve effect.correction of residual stenosis or twist restored graft
patency by angioplasty and stenting. In three patients Finally, despite the fact that the distribution of in-
dividual risk factors was not statistically significant inthis option was not feasible or failed and as a limb
remained patent, a crossover femorofemoral bypass the two groups, more patients in the EV group had
multiple associated severe-risk factors.was performed.
No AAA ruptured, but three patients in the EV Our study confirms the advantages of EV during
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Table 4. Comparison of subsequent vascular, endovascular and miscellaneous interventions in patients with
AAA treated by endovascular or open repair.
Endovascular repair Open repair
n n p
Restoring patency
PTA±stent 7 0
Thrombolysis 2 0
Thrombectomy 1
Femorofemoral graft 3 2
Graft replacement including conversion 3 0
Treating endoleaks
Embolisation 5 0
Proximal cuff 1 0
Distal extension 8 0
Miscellaneous
Haemorrhage 2
Mesenteric infarct 1
Wound dehiscence repair 2
Total (no. patients)∗ 16 8 <0.007
∗ Patient could have more than one reintervention.
the early postoperative period. Operative mortality differences, although not statistically significant, in the
survival rate between open and endovascular repairwas similar (2.8% and 2.7%), confirming previous
studies of May14 and Brewster13 who found respectively with 2-year survival rates of 92% and 88% respectively.
Thus, we agree with the conclusions of May, who5.6% and 0% in both groups. The two early deaths in
the EV group observed in our early practice were stated that endovascular repair is a safe procedure
and that further evaluations may go on.related to graft complications and occurred in high-
risk patients. It may be assumed that, with a greater One key finding of our study is the high incidence
of secondary procedures among the EV group whichexpertise and improvement of the devices, these ser-
ious complications may be avoidable in the future. were necessitated during the follow-up to treat en-
doleak, or improve or restore patency of the graft.The lower requirement for transfusion was notable
in the EV group, as it was in the study of White12 This finding has already been observed in the French
Vanguard study.17 None of our patients had a ruptured(mean 873 ml vs. 1422 ml), Brewster13 (mean 498 ml vs.
1287 ml), and Zarins14 (mean 641 ml vs. 1596 ml). We AAA during the follow-up, but three patients had to
be converted to open surgical repair for obvious failure.found that the total duration of hospitalisation was
reduced by 6 days in the EV group, in agreement with Endoleaks were treated electively according to their
aetiology. Type I endoleak required proximal cuff orthe findings of Brewster13 (3.9 days versus 10.3 days)
and Zarins14 (3.4 days versus 9.4 days). White12 and distal extension and persistent type II endoleak,
lumbar, internal iliac or inferior mesenteric em-Brewster13 also reported a shorter stay in the intensive
care unit for the EV group. EV was also associated bolisation. Not all these attempts were easy, or suc-
cessful. Unexpected acute occlusion of graft limbs waswith fewer general complications as underlined by
previous authors13 (4% versus 18%),14 (3% versus 12%). more dramatic, with the need for urgent hospitalisation
and treatment by thrombolysis and stenting or openIn our series, the most dramatic improvement was the
rate of pulmonary complications, which was reduced surgery. Even if the secondary procedures were mostly
endovascular and did not affect mortality, they are anby 60% with the EV technique.
Vascular complications were infrequent in the cur- obvious drawback for this method as compared to
open repair. The future of EV graft technology forrent series, which can be explained by the use of
commercially available grafts with adequate in- AAA will depend upon the way the late failures
will be prevented. Failure may be divided into threetroducers and the selection of patients who had healthy
external iliac arteries. categories: inadequate sealing during implantation,
graft-related failure, and failure due to AAA evolution.Long-term results of endovascular grafting remain
to be evaluated. We found a slightly higher mortality During implantation, recognition and immediate treat-
ment of type I endoleak is an obvious way of improvingrate in the EV group, which may be explained by a
slightly higher risk group when the association of the results. They require an excellent preoperative
assessment of the aneurysm features, a good technicalmultiple risk factors was analysed. May15 found similar
Eur J Vasc Endovasc Surg Vol 19, June 2000
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